Ravidomycin is an antibiotic compound belonging to the class of anthracyclines, which are known for their potent antibacterial and antitumor properties. It is produced by the fermentation of the bacterium *Micromonospora* species. Ravidomycin exhibits a complex molecular structure characterized by a polycyclic ring system, which is typical of anthracycline antibiotics. Its mechanism of action primarily involves the inhibition of DNA and RNA synthesis, making it effective against a range of bacterial infections. The compound has shown activity against various Gram-positive bacteria and some Gram-negative strains, although its clinical use may be limited due to potential toxicity and resistance issues. Ravidomycin's pharmacological profile includes properties such as cytotoxicity, which is of interest in cancer research. Additionally, it may have immunosuppressive effects, which can be relevant in certain therapeutic contexts. As with many antibiotics, careful consideration of its use is necessary to mitigate the development of resistance and to ensure patient safety.

Ravidomycin

74622-75-6: Ravidomycin is an antibiotic compound belonging to the class of anthracyclines, which are known for their potent antibacterial and antitumor properties. It is produced by the fermentation of the bacterium *Micromonospora* species. Ravidomycin exhibits a complex molecular structure characterized by a polycyclic ring system, which is typical of anthracycline antibiotics. Its mechanism of action primarily involves the inhibition of DNA and RNA synthesis, making it effective against a range of bacterial infections. The compound has shown activity against various Gram-positive bacteria and some Gram-negative strains, although its clinical use may be limited due to potential toxicity and resistance issues. Ravidomycin's pharmacological profile includes properties such as cytotoxicity, which is of interest in cancer research. Additionally, it may have immunosuppressive effects, which can be relevant in certain therapeutic contexts. As with many antibiotics, careful consideration of its use is necessary to mitigate the development of resistance and to ensure patient safety.

<p>Ravidomycin is an antitumor antibiotic. It shows effective anticancer activities against various cancer cell lines in the presence of visible light.</p>

CAS 74622-75-6

Ravidomycin

Ravidomycin

Ref: TM-T26043